168
Participants
Start Date
October 19, 2020
Primary Completion Date
November 9, 2022
Study Completion Date
Denosumab
60 mg, single-dose
Biotrial, Newark
Biotrial Rennes, Rennes
Samsung Bioepis Co., Ltd.
INDUSTRY